ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivoChristian Moser, Oliver Stoeltzing|BMC Cancer|2008Cited by 70